NYSE

Ingevity Corporation (NGVT)

341 Thanks from members

Ingevity Corporation (NGVT) demonstrates a solid financial turnaround in Q2 2026, featuring strong profit rebounds, a raised full-year outlook, aggressive share buybacks, and an ongoing strategic portfolio reshaping under the "New Ingevity" framework.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →